Remed Co.,Ltd. (KOSDAQ:302550)
3,180.00
+5.00 (0.16%)
At close: Mar 6, 2026
Remed Market Cap
Remed has a market cap or net worth of 95.19 billion as of March 9, 2026. Its market cap has decreased by -8.35% in one year.
Market Cap
95.19B
Enterprise Value
86.36B
Revenue
24.26B
Ranking
n/a
PE Ratio
29.74
Stock Price
3,180.00
Market Cap Chart
Since August 14, 2018, Remed's market cap has increased from 73.83B to 95.19B, an increase of 28.93%. That is a compound annual growth rate of 3.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 95.19B | 0.33% |
| Dec 30, 2025 | 94.88B | -13.97% |
| Dec 30, 2024 | 110.30B | 10.60% |
| Dec 28, 2023 | 99.73B | 31.78% |
| Dec 29, 2022 | 75.68B | -53.48% |
| Dec 30, 2021 | 162.69B | -18.29% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| L&K Biomed | 225.08B |
| SELVAS Healthcare | 114.44B |
| Noul Co.,Ltd. | 81.76B |
| QuantaMatrix | 76.92B |
| Hironic | 74.74B |
| Neofect | 65.85B |
| JPI Healthcare | 62.80B |
| DRGEM | 56.11B |